⚠ Everything below is a research-use overview of mechanisms and study context. Patriot Labs products are sold for in-vitro research and laboratory use only. This is not medical advice, dosing guidance, or a claim that any compound produces weight loss in humans.

In this guide

  1. How metabolic peptides are studied
  2. Quick comparison
  3. Retatrutide
  4. Cagrilintide
  5. AOD-9604
  6. MOTS-c
  7. How researchers choose and combine
  8. FAQ

How metabolic peptides are studied

Most of the peptides in this category act on the body's appetite and energy-use signaling — the systems that tell the brain when you're full and tell tissues how to handle fuel. The headline class is the incretins: gut hormones like GLP-1 and GIP that influence blood sugar and satiety. Research peptides in this space are designed to engage those receptors, sometimes several at once. Other compounds work on entirely separate pathways — amylin signaling, fat metabolism, or mitochondrial energy — which is why they're often studied side by side or in combination.

Quick comparison

PeptideClass / pathwayStudied for
RetatrutideTriple agonist (GLP-1 / GIP / glucagon)Broadest metabolic engagement of the group
CagrilintideAmylin analogSatiety signaling; complementary to incretins
AOD-9604Modified GH fragmentFat-metabolism-focused research
MOTS-cMitochondrial-derived peptideCellular energy and metabolic regulation

Retatrutide

Retatrutide is the current frontier of incretin research: a single molecule that activates three metabolic receptors at once — GLP-1, GIP, and glucagon. That third arm, the glucagon receptor, is what sets it apart from earlier single- and dual-agonist compounds, because glucagon activation is tied to energy expenditure through the liver and thermogenic pathways. It engages the widest metabolic network of anything in this list, which is why it dominates current metabolic research. We cover the mechanism in depth in What Is Retatrutide?

Cagrilintide

Cagrilintide comes at metabolism from a different angle entirely. It's an amylin analog — amylin is a hormone co-released with insulin that promotes a feeling of fullness and slows stomach emptying. Because that pathway is separate from the incretin system, Cagrilintide is frequently studied alongside incretin compounds rather than against them: the two mechanisms stack rather than overlap. That complementarity is exactly why it's become one of the most-watched metabolic peptides.

AOD-9604

AOD-9604 is a modified fragment of human growth hormone — specifically the tail end of the molecule associated with fat metabolism, without the full growth-hormone activity. It's studied for its role in how the body mobilizes and breaks down fat, making it a different tool from the appetite-focused incretins. Researchers interested in fat-metabolism pathways rather than satiety signaling tend to look here.

MOTS-c

MOTS-c is a mitochondrial-derived peptide — encoded within the DNA of the mitochondria, the tiny power plants inside your cells. It's studied for its role in cellular energy metabolism and metabolic regulation, a fundamentally different mechanism from the receptor-agonist compounds above. It shows up in metabolic research where the focus is on energy handling at the cellular level rather than appetite. It also appears in our anti-aging and longevity guide, since those pathways overlap.

How researchers choose and combine

Because these compounds hit different pathways, the interesting research questions are often about how they compare and combine. The incretin agonists (Retatrutide) and the amylin analog (Cagrilintide) are studied together precisely because their mechanisms complement each other. Fat-metabolism compounds (AOD-9604) and mitochondrial peptides (MOTS-c) represent separate angles again. There's no single "best" — the right reference compound depends on which pathway a study is examining.

On the practical side, all of these arrive as freeze-dried powder and need to be reconstituted and stored correctly, and our reconstitution calculator handles the concentration math.

Explore the metabolic lineup. Every compound above is third-party tested and USA-sourced, with published COAs where available.

Shop Research Peptides

Frequently asked questions

Which peptides are most studied for weight loss? The incretin agonists lead — especially Retatrutide — alongside the amylin analog Cagrilintide, plus AOD-9604 and MOTS-c, each engaging a different metabolic pathway.

What's the difference between Retatrutide and Cagrilintide? Retatrutide is a triple incretin agonist (GLP-1/GIP/glucagon); Cagrilintide is an amylin analog working through satiety signaling. Different pathways, often studied in combination.

Are these approved for human use? No. They're sold strictly for in-vitro research and laboratory use only and are not intended for human consumption.

All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. This guide describes research context and mechanisms in general terms; it is not medical advice and makes no claims about outcomes in humans.